« Coordinated Remedies: Convergence, Cooperation, and the Role of Transparency | Main | Antirust Law: Merger Control and Dynamic Market Processes »
February 20, 2010
The Role of Static and Dynamic Analysis in Pharmaceutical Antitrust
Posted by D. Daniel Sokol
Tom Rosch (FTC) has given a speech on The Role of Static and Dynamic Analysis in Pharmaceutical Antitrust.
February 20, 2010 | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef01310f21793e970c
Listed below are links to weblogs that reference The Role of Static and Dynamic Analysis in Pharmaceutical Antitrust:
